Renascience (TSE:4889) Retained Earnings: 円-1,136.33 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4889 Renascience Inc TSE:4889
51 GF Score
Price 円1,148.00
GF Value 円305.40
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Renascience Retained Earnings?

Renascience TSE:4889 -6.67% 51 Retained Earnings is 円-1,136.33 Mil as of Mar. 2026. GuruFocus rates TSE:4889 with a GF Score™ of 51/100 and a GF Value™ of 円305.40 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Renascience's retained earnings for the quarter that ended in Mar. 2026 was 円-1,136.33 Mil.

Renascience's quarterly retained earnings declined from Sep. 2025 (円-986.78 Mil) to Dec. 2025 (円-1,053.37 Mil) and declined from Dec. 2025 (円-1,053.37 Mil) to Mar. 2026 (円-1,136.33 Mil).

Renascience's annual retained earnings increased from Mar. 2024 (円-948.48 Mil) to Mar. 2025 (円-835.05 Mil) but then declined from Mar. 2025 (円-835.05 Mil) to Mar. 2026 (円-1,136.33 Mil).


Renascience  (TSE:4889) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Renascience Retained Earnings Historical Data

* Premium members only.

The historical data trend for Renascience's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Renascience Retained Earnings Chart

Renascience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Retained Earnings
Get a 7-Day Free Trial -354.35 -690.14 -948.48 -835.05 -1,136.33

Renascience Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -901.93 -986.78 -1,053.37 -1,136.33 -1,218.37
TSE:4889
51GF Score
Renascience Inc TSE:4889
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Renascience Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of 円-1,136.33 Mil mean?
Renascience (TSE:4889) has a Retained Earnings of 円-1,136.33 Mil as of Mar. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Renascience and its competitors.
Is Renascience's Retained Earnings too high?
Renascience's current Retained Earnings is 円-1,136.33 Mil. Overall, Renascience has a GF Score™ of 51/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Renascience's Retained Earnings compare to ABT and SYK?
Renascience's Retained Earnings of 円-1,136.33 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Medical Devices & Instruments company?
A good Retained Earnings depends on the Medical Devices & Instruments industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Renascience and its competitors. Renascience's current Retained Earnings is 円-1,136.33 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Renascience stock overvalued right now?
Based on GuruFocus' analysis, Renascience (TSE:4889) is currently considered Significantly Overvalued. The stock's GF Value™ is 円305.40, compared to a current price of 円1,148.00 — trading 275.9% above its estimated fair value. The current Retained Earnings is 円-1,136.33 Mil. Renascience's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Renascience (TSE:4889), the current Retained Earnings is 円-1,136.33 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Renascience (TSE:4889) Overvalued in 2026?

Based on GuruFocus' analysis, Renascience stock appears to be overvalued. The current stock price of 円1,148.00 is trading 275.9% above its estimated GF Value™ of 円305.40. GuruFocus considers Renascience to be Significantly Overvalued.

Key valuation signals for TSE:4889:

  • Retained Earnings: 円-1,136.33 Mil
  • GF Value™: 円305.40 vs. price of 円1,148.00 (275.9% above fair value)
  • GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the TSE:4889 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Renascience Business Description

Address 2-1 Seiryo-cho, Aoba-ku, Miyagi, Sendai, JPN, 103-0023
Renascience Inc is engaged in the Development and commercialization of pharmaceuticals, medical devices, pieces of software as a medical device (SaMD) utilizing AI, etc.
51GF Score

Get the complete analysis for TSE:4889

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,148.00
Price
円305.40
GF Value